To test this hypothesis, we assessed CD31-stained cells in these xenograft tumors and found a decrease in tumor microvessel density (MVD) in the tumors receiving paclitaxel plus MANS peptide (Figure 6A, top; mean MVD, 0.7% area). This evidence concerns the gene PECAM1 and neoplasm.